Veritas Pharma Inc. announced earnings results for the third quarter ended January 31, 2021. For the third quarter, the company announced net loss was CAD 98,154 compared to CAD 256,074 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago. For the nine months, net loss was CAD 507,130 compared to CAD 1.409 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.12 a year ago.